0001493152-20-024462.txt : 20201229 0001493152-20-024462.hdr.sgml : 20201229 20201229164416 ACCESSION NUMBER: 0001493152-20-024462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201207 FILED AS OF DATE: 20201229 DATE AS OF CHANGE: 20201229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROIDRICK AMY S. CENTRAL INDEX KEY: 0001822917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 201422957 MAIL ADDRESS: STREET 1: 1440 VALLE GRANDE CITY: ESCONDIDO STATE: CA ZIP: 92025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 4 1 ownership.xml X0306 4 2020-12-07 0 0001460702 Qualigen Therapeutics, Inc. QLGN 0001822917 BROIDRICK AMY S. C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL CARLSBAD CA 92011 1 1 0 0 Executive VP, CSO Stock Option (Right to Buy) 3.52 2020-12-07 4 A 0 150000 0 A 2030-12-07 Common Stock 150000 150000 D Shares underlying the stock option vest over three years in equal annual installments from the date of grant. /s/ Hayden Trubitt, Attorney-in-Fact for Amy S. Broidrick 2020-12-29